Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000184315
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
||
|
NDF-RT |
N0000184316
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
19.1
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11601
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
92129-86-7
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
N0000011417
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | Antigens, Bacterial [Chemical/Ingredient] | ||
|
SUB12379MIG
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
m11255
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
8948
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | RxNorm | ||
|
I7L8FKN87J
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
I7L8FKN87J
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Sat Dec 16 00:14:46 GMT 2023 , Edited by admin on Sat Dec 16 00:14:46 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] |
ACTIVE MOIETY